Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance

β-Hemolytic streptococci are frequently implicated in necrotizing soft-tissue infections (NSTIs). Clindamycin administration may improve outcomes in patients with serious streptococcal infections. However, clindamycin resistance is growing worldwide, and resistance patterns in NSTIs and their impact...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2021-12, Vol.73 (11), p.e4592-e4598
Hauptverfasser:	Horn, Dara L, Roberts, Emma A, Shen, Jolie, Chan, Jeannie D, Bulger, Eileen M, Weiss, Noel S, Lynch, John B, Bryson-Cahn, Chloe, Robinson, Bryce R H
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Clindamycin - pharmacology Clindamycin - therapeutic use Humans Online Only Soft Tissue Infections - drug therapy Soft Tissue Infections - epidemiology Streptococcal Infections - complications Streptococcal Infections - drug therapy Streptococcal Infections - epidemiology Streptococcus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!